Literature DB >> 23142009

Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Paul T King1, Steven Lim, Adrian Pick, James Ngui, Zdenka Prodanovic, William Downey, Cliff Choong, Anthony Kelman, Elizabeth Baranyai, Michelle Francis, Randall Moshinsky, Philip G Bardin, Peter W Holmes, Stephen R Holdsworth.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation that persists after the cessation of smoking. T cells have a major role in driving inflammation in patients with COPD and are activated by specific antigens to produce mediators, such as cytokines. The antigens that activate lung T cells have not been clearly defined. Nontypeable Haemophilus influenzae (NTHi) is the dominant bacterium isolated from the lungs of patients with COPD.
OBJECTIVE: We sought to measure the response of lung tissue T cells to stimulation with NTHi.
METHODS: We obtained lung tissue from 69 subjects having lobectomies for lung cancer. Of the group, 39 subjects had COPD, and 30 without COPD were classified as control subjects. The lung tissue was dispersed into single-cell suspensions and stimulated with live NTHi. Cells were labeled with antibodies for 5 important inflammatory mediators in patients with COPD and analyzed by using flow cytometry.
RESULTS: NTHi produced strong activation of both TH cells and cytotoxic T cells in the COPD cohort. The COPD cohort had significantly higher levels of cells producing TNF-α, IL-13, and IL-17 in both T-cell subsets. When control subjects were divided into those with and without a significant smoking history and compared with patients with COPD, there was a progressive increase in the numbers of T cells producing cytokines from nonsmoking control subjects to smoking control subjects to patients with COPD.
CONCLUSION: NTHi activates lung T cells in patients with COPD. This proinflammatory profibrotic response might be a key cause of inflammation in patients with COPD and has implications for treatment.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23142009     DOI: 10.1016/j.jaci.2012.09.030

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

Review 1.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

2.  Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

Authors:  Vandana Gupta; Antonia Banyard; Aoibheann Mullan; Srividya Sriskantharajah; Thomas Southworth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

Review 3.  Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children.

Authors:  Anne B Chang; Robyn L Marsh; John W Upham; Lucas R Hoffman; Heidi Smith-Vaughan; Deborah Holt; Maree Toombs; Catherine Byrnes; Stephanie T Yerkovich; Paul J Torzillo; Kerry-Ann F O'Grady; Keith Grimwood
Journal:  Front Pediatr       Date:  2015-02-13       Impact factor: 3.418

4.  Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.

Authors:  Paul T King; Roleen Sharma; Kim O'Sullivan; Stavros Selemidis; Steven Lim; Naghmeh Radhakrishna; Camden Lo; Jyotika Prasad; Judy Callaghan; Peter McLaughlin; Michael Farmer; Daniel Steinfort; Barton Jennings; James Ngui; Bradley R S Broughton; Belinda Thomas; Ama-Tawiah Essilfie; Michael Hickey; Peter W Holmes; Philip Hansbro; Philip G Bardin; Stephen R Holdsworth
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 5.  The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).

Authors:  Paul T King; Roleen Sharma
Journal:  J Immunol Res       Date:  2015-05-31       Impact factor: 4.818

6.  Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae.

Authors:  Susan J Pizzutto; Stephanie T Yerkovich; John W Upham; Belinda J Hales; Wayne R Thomas; Anne B Chang
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

7.  Lung CD8+ T cells in COPD have increased expression of bacterial TLRs.

Authors:  Christine M Freeman; Fernando J Martinez; Meilan K Han; George R Washko; Alexandra L McCubbrey; Stephen W Chensue; Douglas A Arenberg; Catherine A Meldrum; Lisa McCloskey; Jeffrey L Curtis
Journal:  Respir Res       Date:  2013-02-01

8.  Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.

Authors:  Mona Bafadhel; Koirobi Haldar; Bethan Barker; Hemu Patel; Vijay Mistry; Michael R Barer; Ian D Pavord; Christopher E Brightling
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-09

9.  Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.

Authors:  Paul T King
Journal:  Clin Transl Med       Date:  2015-07-29

10.  Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells.

Authors:  Seamus Grundy; Jonathan Plumb; Manminder Kaur; David Ray; Dave Singh
Journal:  Respir Res       Date:  2016-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.